CAMARILLO, Calif., Dec. 2, 2025 /PRNewswire/ -- PBS Biotech ("PBS"), a leader in single-use bioreactor technology, today announced the launch of MiniPRO™, a multi-parallel Vertical-Wheel ® bioreactor ...

With their domestic profits narrowing and production capacity expanding, China’s firms are continuing to widen their overseas footprints in search of new, more lucrative markets. In this series, we ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Beverly biotech is working ...

SAN DIEGO, December 16, 2025--(BUSINESS WIRE)--Oncolytics Biotech ® Inc. (Nasdaq: ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today announced ...

A Chinese biopharmaceutical firm has sealed a global licensing deal valued at up to US$1.44 billion, the second in a week, as a wave of cross-border tie-ups shows no sign of abating despite headwinds ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min This Cambridge biotech is ...

33% ORR achieved in second-line KRAS-mutant MSS colorectal cancer—triple historical response rates for Avastin + FOLFIRI of 6-11% In addition to the clinical activity, a separate translational ...

A key late-stage trial of Arcus Biosciences and Gilead Sciences' anti-TIGIT antibody domvanalimab has flopped, leading Arcus to refocus its R&D priorities and abandon several studies of the drug. The ...

Vivek Ramaswamy has found time out of his campaign for governor of Ohio to launch a new biotech. The new firm, Ambros Therapeutics, debuted Tuesday with a $125 million series A and plans to develop a ...

We've identified the following companies as similar to Cardiac Biotech Solutions Inc. because they operate in a related industry or sector. We also considered size, growth, and various financial ...

The 2025 conference brings together leading academics and industry professionals to explore developments and challenges in the rapidly evolving field of nucleic acid medicines. By uniting researchers ...